PGEN

Precigen Inc.

Price

$8.30

return (12m)

155.23%

p/e

-18.77

p/bv

67.94

DIVIDEND YIELD

0.00%

PGEN price

Precigen

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PGEN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

16.10%

3 months

46.43%

1 year

155.23%

2 years

798.99%

5 years

64.58%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PGEN

Valuation

P/E

-18.77

Sector -3.46

Industry -3.46

P/BV

67.94

Sector 1.94

Industry 1.94

P/Revenue (PSR)

37.84

Sector 1.96

Industry 1.96

EV/EBITDA

125.02

Sector -216.42

Industry -216.42

EV/EBIT

131.00

Sector -46.11

Industry -46.11

P/EBITDA

-20.58

Sector -21.02

Industry -21.02

P/EBIT

-20.01

Sector -27.60

Industry -27.60

P/Total Assets

17.38

Sector 1.14

Industry 1.14

P/Net Current Assets

386.28

Sector -10.24

Industry -10.24

P/Working Capital

28.19

Sector -162.19

Industry -162.19

EPS

-0.44

Sector -1.78

Industry -1.78

BVPS

0.12

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

93.14%

Sector 41.35%

Industry 41.35%

EBITDA Margin

43.88%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

41.88%

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

-50.49%

Sector -35.47%

Industry -35.47%

Net Profit Margins

-100.00%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.32

Sector 0.03

Industry 0.03

Profitability

ROE

-361.91%

Sector -57.40%

Industry -57.40%

ROA

-92.61%

Sector -59.43%

Industry -59.43%

ROIC

101.83%

Sector -2,370.21%

Industry -2,370.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.58

Sector 2.91

Industry 2.91

Net Debt / EBITDA

2.31

Sector -21.98

Industry -21.98

Net Debt / EBIT

2.42

Sector -8.44

Industry -8.44

Net Debt / Equity

1.28

Sector -33,112.99

Industry -33,112.99

Gross Debt / Equity

2.15

Sector -0.85

Industry -0.85

Equity/Assets

0.26

Sector 0.46

Industry 0.46

Liabilities/Assets

0.74

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

19.83%

Sector -

Industry -

5Y Earnings CAGR

11.34%

Sector -

Industry -

Fundamentals PGEN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PGEN Precigen Inc.	$8.30	148.35%	0.00%	-18.77	67.94	-361.91%	-100.00%
PFE Pfizer Inc.	$27.48	8.11%	6.26%	36.14	1.83	5.07%	6.80%
ABBV AbbVie Inc.	$259.97	9.77%	2.63%	72.88	-77.57	-106.44%	9.81%
NVO Novo Nordisk A/S	$37.23	-33.47%	4.98%	9.10	4.83	53.11%	35.32%
MRK Merck & Co. Inc.	$143.18	65.09%	2.36%	110.80	8.37	7.56%	4.77%
AZN AstraZeneca PLC	$156.59	-4.79%	2.06%	18.71	4.82	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$60.33	34.59%	4.20%	13.14	5.46	41.59%	18.87%
ZTS Zoetis Inc.	$69.46	-51.82%	3.01%	11.00	9.21	83.77%	27.69%
AMGN Amgen Inc.	$402.15	38.44%	2.47%	24.84	18.58	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$729.88	22.13%	0.51%	17.33	2.37	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$108.98	45.42%	0.00%	30.90	89.03	288.13%	24.86%
MCK McKesson Corporation	$888.29	16.56%	0.38%	22.96	-27.29	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$501.27	24.01%	0.00%	28.87	6.28	21.76%	35.00%
CAH Cardinal Health Inc.	$226.17	45.05%	0.91%	30.94	-19.47	-62.92%	0.67%
ARGX argenx SE	$914.13	19.13%	0.00%	20.47	5.36	26.20%	25.70%
HRMY Harmony Biosciences Holdings Inc.	$39.41	46.40%	0.00%	12.60	2.28	18.14%	18.88%
BIIB Biogen Inc.	$220.34	42.87%	0.00%	38.99	1.73	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PGEN - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Precigen

Precigen Inc.

Average Investor10 user rating

4.0 (0 people)

United States

28 years

Founded: 1998

2013

Time since IPO - 13 years

680

Employees

Precigen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.96 billion, with shareholders equity totaling $43.58 million.

The company employs approximately 680 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Precigen Inc. reported $78.23 million in revenue, generating net income of $-157.71 million.

Key financial metrics include a P/E ratio of -18.77, a price-to-book (P/B) ratio of 67.94, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PGEN.

Market cap

$2.96 billion

Net worth

$43.58 million

$43,576,000.00

Assets

$170.30 million

$170,296,000.00

Total Shares Outstanding

356.89 million

356,893,000

Average Daily Trading Volume

$5.33 million

$5,326,399.18

Sector

Health Care

Industry

Biotechnology

PGEN

PGEN revenue and profits

Financial Results PGEN

DRAG THE FRAME TO SEE MORE DATA

PGEN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$888.29 20,83% (12M)

P/E

22.96

0.38%

ROE

-118.84%

P/BV

-27.29

CAH - Cardinal Health

$226.17 47,96% (12M)

P/E

30.94

0.91%

ROE

-62.92%

P/BV

-19.47

ABBV - AbbVie

$259.97 14,69% (12M)

P/E

72.88

2.63%

ROE

-106.44%

P/BV

-77.57

MRK - Merck & Co.

$143.18 65,85% (12M)

P/E

110.80

2.36%

ROE

7.56%

P/BV

8.37

AZN - AstraZeneca

$156.59 --6,84% (12M)

P/E

18.71

2.06%

ROE

25.77%

P/BV

4.82

PFE - Pfizer

$27.48 7,47% (12M)

P/E

36.14

6.26%

ROE

5.07%

P/BV

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12M)

P/E

13.14

4.20%

ROE

41.59%

P/BV

5.46

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$888.29 20,83% (12 M)

P/L

22.96

0.38%

ROE

-118.84%

P/VP

-27.29

CAH - Cardinal Health

$226.17 47,96% (12 M)

P/L

30.94

0.91%

ROE

-62.92%

P/VP

-19.47

ABBV - AbbVie

$259.97 14,69% (12 M)

P/L

72.88

2.63%

ROE

-106.44%

P/VP

-77.57

MRK - Merck & Co.

$143.18 65,85% (12 M)

P/L

110.80

2.36%

ROE

7.56%

P/VP

8.37

AZN - AstraZeneca

$156.59 --6,84% (12 M)

P/L

18.71

2.06%

ROE

25.77%

P/VP

4.82

PFE - Pfizer

$27.48 7,47% (12 M)

P/L

36.14

6.26%

ROE

5.07%

P/VP

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12 M)

P/L

13.14

4.20%

ROE

41.59%

P/VP

5.46

Frequently Asked Questions

What is the price of Precigen (PGEN) today?

The current price of Precigen (PGEN) is $8.30. The stock began the year trading around $4.18 and is currently priced at $8.30. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Precigen (PGEN) pay dividends?

Precigen (PGEN) did not pay dividends over the past year.

Is Precigen (PGEN) a good investment?

Precigen (PGEN) is currently trading at $8.30 with a P/E ratio of -18.77. This represents a -842% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 155.23%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Precigen (PGEN) stock?

You can buy Precigen (PGEN) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol PGEN and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Precigen (PGEN) yield today?

Over the past month, Precigen (PGEN) has returned 16.10% — 155.23% over the past year, and 64.58% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Precigen (PGEN) today at the current price of $8.30 your total investment would be $829.50.

Based on historical performance, the investment would have grown to approximately:

$2,117.13 after 1 year
$1,365.19 after 5 years
$829.50 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PGEN

Precigen Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PGEN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PGEN WITH OTHER STOCK

ABOUT Precigen

Precigen Inc.

United States

28 years

2013

680

PROFIT X PRICE PGEN

Financial Results PGEN

PGEN cash flow

Asset, Revenue and Profit Growth - PGEN

PGEN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions